Key Findings: Thermo Fisher Scientific Leads Bioprocess Optimization with AI-Driven Digital Twins
Thermo Fisher Scientific is at the forefront of AI technology adoption, seeking a Data Scientist to spearhead the development of digital twin models specifically for CHO cell culture and upstream bioprocess workflows. This initiative aims to drastically improve predictive capabilities and control precision in bioprocesses, contributing to enhanced efficiency and quality assurance in pharmaceutical manufacturing.
Technical and Clinical Details: Predictive Simulations via Hybrid Modeling
- Digital Twin Model Development: The Data Scientist will be responsible for building digital twins—virtual models—of the entire CHO cell culture process. These digital twins will acquire real-time data from the physical process to simulate and predict behavior.
- Integration of AI, Machine Learning, and Bayesian Optimization: Hybrid modeling approaches will be employed, combining traditional mechanistic models with data-driven models. AI and machine learning will be used to learn complex biological reaction patterns, while Bayesian optimization will explore optimal process conditions while accounting for model uncertainties.
- Targets for Predictive Simulation: Critical cell culture process parameters such as nutrient depletion, metabolite accumulation, cell growth rate, and target protein productivity will be subject to prediction. This enables early detection of potential variations or issues during the process.
- Real-time Prediction and Corrective Actions: By performing these predictions in real-time or near real-time, process deviations can be detected early, allowing systems to automatically, or through operator recommendations, implement corrective actions. This reduces the risk of batch failures and improves production efficiency and quality consistency.
Background and Industry Context: Complexity of Biopharmaceutical Manufacturing and Need for Data Utilization
Biopharmaceutical manufacturing, particularly cell culture processes, is a complex system with numerous interacting variables. Even minor fluctuations can significantly impact the quality and yield of the final product. Therefore, deep process understanding and precise control are indispensable. Recently, with the proliferation of IoT sensors, vast amounts of data have become available, and the industry is rapidly moving to analyze and leverage this data with AI to achieve process ‘visibility’ and ‘optimization.’
Future Outlook: Foundational Technology for Smart Biomanufacturing
This initiative by Thermo Fisher Scientific signals the acceleration of digital transformation in biomanufacturing. AI-driven digital twins will serve as a foundational technology supporting decision-making across the entire bioprocess lifecycle, from process design and scale-up to commercial production and quality control. This is expected to contribute to reducing time-to-market for new drugs, lowering manufacturing costs, and ultimately ensuring a stable supply of safer, higher-quality medicines to patients. In the future, such predictive control systems are anticipated to become standard manufacturing platforms.
Source: https://haystackapp.io/jobs/167bdfcd-4458-4fcc-b0af-0ba85bc0aa52
Get our weekly technology intelligence — free
Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.
Subscribe Free — Weekly Tech Intelligence
By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.
- Your email and selected fields are used only to deliver the newsletter.
- We never share your information with third parties.
- You can unsubscribe anytime via the link in each email.
See our Privacy Policy for details.
Takes about a minute · Unsubscribe anytime
Comments